electroCore to Participate at Two Upcoming Investor Conferences
Format: pre-recorded fireside chat followed by 1x1 virtual investor meetings
The fireside chat will be available for viewing beginning on
Following the conference a webcast replay of the presentation will be available for 90 days on the Investor section of the company’s website, www.electrocore.com
Format: pre-recorded corporate presentation followed by 1x1 virtual investor meetings
The presentation will be available for viewing beginning on
Investors can register for the conference HERE.
About electroCore, Inc.
electroCore, Inc. is a commercial stage bioelectronic medicine company dedicated to improving patient outcomes through its platform non-invasive vagus nerve stimulation therapy initially focused on the treatment of multiple conditions in neurology. The company’s current indications are the adjunctive use for the preventive treatment of cluster headache in adult patients, the acute treatment of pain associated with episodic cluster headache in adult patients, and the acute and preventive treatment of migraine in adolescent (ages 12 and older) and adult patients.
For more information, visit www.electrocore.com.